Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer
ConditionLocalized Breast Cancer
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age65+
SponsorCentre Antoine Lacassagne
About this trial
Phase II study; open recruitment, multicentrique. The aim of this clinical research is to evaluate faisability and toxicity of the per-operative radiotherapy using PAPILLON + TM device for localized breast cancers patients over 65 years.
Eligibility criteria
Qualifiers
Patient with invasive ductal adenocarcinoma <=2cm, evaluate on all radiological exams;
Women aged 65 years or older (patients 65 years of age in the year may be included);
Grade 1 or 2 unifocal adenocarcinoma, all index KI67, positive HR, negative HER2 status;
T0 or T1, N0 radio-clinic;
Disqualifiers
Age less than 65 years (except if 65 years obtained during the year)
Patient with an exclusive in situ carcinoma
Patient with lymphatic invasion / peri-nerve involvement / vascular emboli
Patient with a lobular adenocarcinoma
Trial design
Treatments tested in this trial
- Per-Operative Radiotherapy technique by Papillon +TM
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov